Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Biomedical Chromatography : BMC|December 7, 2019
Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability resultsArd van Veelen, Robin van Geel, Yvo de Beer, et al.Pharmacoepidemiology and Drug Safety|January 14, 2026
Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry DataPaul D Kruithof, Patrick C Souverein, Johanna H M Driessen, et al.Melanoma Research|August 25, 2021
Nivolumab exposure in a hemodialysis patient with metastatic melanomaJudith L Gulikers, Sander Croes, Marco J W Schreurs, et al.Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.Lung Cancer (Amsterdam, Netherlands)|August 7, 2022
Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trialArd van Veelen, Judith Gulikers, Lizza E L Hendriks, et al.The Oncologist|February 8, 2017
Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid TumorsMaikel Verduin, Jaap D Zindler, Hanneke M A Martinussen, et al.European Journal of Drug Metabolism and Pharmacokinetics|June 15, 2024
Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung CancerNiels Westra, Paul D Kruithof, Sander Croes, et al.Cancer Epidemiology|April 16, 2022
Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitorsArd van Veelen, Shahab Abtahi, Patrick Souverein, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 18, 2023
Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIsPaul D Kruithof, Yvo M de Beer, Judith L Gulikers, et al.Journal of Pharmaceutical and Biomedical Analysis|November 8, 2017
Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology settingLotte M Knapen, Yvo de Beer, Roger J M Brüggemann, et al.Pageof 5